Results 31 to 40 of about 11,553 (254)

Extracorporeal membrane oxygenation and microaxial left ventricular assist device in cardiogenic shock: Choosing the right mechanical circulatory support to improve outcomesCentral MessagePerspective

JTCVS Open, 2023
Objective: To evaluate the outcomes of patients supported with Impella (CP/5.0) or venoarterial extracorporeal membrane oxygenation (VA-ECMO) for cardiogenic shock according to shock phenotype. The primary end point was 30-day survival.
Olina Dagher, MD, Pierre-Emmanuel Noly, MD, PhD, Walid Ben Ali, MD, PhD, Nadia Bouabdallaoui, MD, PhD, Lucian Geicu, MD, Roxanne Lamanna, Pavan Malhi, BScN, Elizabeth Romero, Anique Ducharme, MD, MSc, Philippe Demers, MD, MSc, Yoan Lamarche, MD, MSc   +10 more
doaj   +1 more source

Giant cell myocarditis masquerading as orbital myositis with a rapid, fulminant course necessitating mechanical support and heart transplantation. [PDF]

, 2017
Giant cell myocarditis (GCM), a rapidly progressive inflammation of the myocardium, is associated with fulminant heart failure, refractory ventricular arrhythmias, and conduction system abnormalities.
Aksoy, Olcay, Ardehali, Reza, Garg, Vinisha, Huynh, Tracy, Shah, Janki, Tan, Weiyi   +5 more
core   +1 more source

Impella CP to Impella 5.5 Uninterrupted Upgrade Using a Double Device Technique

ASAIO Journal, 2022
For the first time, we present a novel technique that enables the exchange of the Impella CP (Abiomed Inc., Danvers, Massachusetts, USA) to the Impella 5.5 (Abiomed Inc.) with no interruption of mechanical support in patients with minimal left ventricular reserve.
Ismael Salas De Armas, Manish K. Patel, Mehmet Akay, Jayeshkumar Patel, Branislav Stojkovic, Biswajit Kar, Igor D Gregoric   +6 more
openaire   +3 more sources

Impella insertion for residual aortic dissection [PDF]

Clinical Case Reports, 2021
Acute aortic dissection with coronary malperfusion is a life-threatening disease, resulting in demanding postoperative management. We report a successful insertion of percutaneous heart pump Impella through the intact true lumen in a patient with residual aortic dissection after the graft replacement and its recovery from the post-cardiotomy ...
Hisashi Yoshida, Yuki Ichihara, Ryogo Hoki, Hiroshi Niinami   +3 more
openaire   +3 more sources

Benefit With Impella?

Journal of the American College of Cardiology, 2010
We are concerned about the report from the Europella registry ([1][1]), which described the use of the Impella 2.5 device (ABIOMED Inc., Danvers, Massachusetts) in 144 European patients undergoing elective high-risk coronary intervention. If this device or any other has merit in an elective, high-
Garratt, Kirk N., Holmes, David R.
openaire   +2 more sources

Impella 5.0 supported oncological surgery as bridge to LVAD

ESC Heart Failure, 2021
We describe the case of a 58‐year‐old man presenting with myocardial infarction complicated by cardiogenic shock, treated with Impella CP which was escalated to an axillary 5.0 due to lack of cardiac recovery.
Andrea Montisci, Giancarlo Micheletto, Serena Sibilio, Francesco Donatelli, Maurizio Tespili, Carlo Banfi, Francesco Casilli, Daniele Cosseta, Antonio Miceli, Silvia Cirri, Federico Pappalardo   +10 more
doaj   +1 more source

Surgical embolectomy for acute massive pulmonary embolism: state of the art [PDF]

, 2018
Massive pulmonary embolism (PE) is a severe condition that can potentially lead to death caused by right ventricular (RV) failure and the consequent cardiogenic shock.
De Bellis, Antonio, D’Abramo, Mizar, Frati, Giacomo, Greco, Ernesto, Iaccarino, Alessandra, Iovine, Elio, Saade, Wael, Schirone, Leonardo, Sciarretta, Sebastiano   +8 more
core   +1 more source

Enhanced recovery from fulminant myocarditis by treatment with the combined use of the Impella left ventricular assist device with extracorporeal membrane oxygenation: a case series

JA Clinical Reports, 2022
Background We experienced two adult cases of fulminant myocarditis with severe cardiogenic shock where Impella left ventricular assist device [left ventricle (LV)-Impella] was concomitantly used with venoarterial extracorporeal membrane oxygenation (V-A ...
Hideyuki Nandate, Tasuku Nishihara, Yukihiro Nakata, Taisuke Hamada, Yasushi Takasaki, Toshihiro Yorozuya   +5 more
doaj   +1 more source

Coronary angiography in heart failure: when and why? Uncertainty reigns [PDF]

, 2017
No abstract ...
Petrie, Mark C., Rocchiccioli, Paul
core   +1 more source

Short‐term outcomes of heart transplant patients bridged with Impella 5.5 ventricular assist device

ESC Heart Failure, 2023
Aims We sought to investigate the outcomes of heart transplant patients supported with Impella 5.5 temporary mechanical circulatory support. Methods and results Patient demographics, perioperative data, hospital timeline, and haemodynamic parameters were
Osama Haddad, Basar Sareyyupoglu, Rohan M. Goswami, Macit Bitargil, Parag C. Patel, Samuel Jacob, Magdy M. El‐Sayed Ahmed, Juan Carlos Leoni Moreno, Daniel S. Yip, Kevin Landolfo, Si M. Pham   +10 more
doaj   +1 more source